GRM5 and depressive symptom measurement: mGlu5 activity has long been implicated in the neuropathology of depression and other stress-related disorders (cf. Spooren et al., 2010; Peterlik et al., 2016; Kasten et al., 2019; Dogra and Conn, 2021).